Company chart and information is provided by TradingView based on 15-minute-delayed data.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.
| Website: | www.clearsidebio.com |
| Email: | ir@clearsidebio.com |
| Main Phone: | +1 678 270-3631 |
| Address: | 900 North Point Parkway |
| Address 2: | Suite 200 |
| State: | GA |
| City / Town: | Alpharetta |
| Country: | US |
| Postal Code: | 30005 |
| Exchange: | NSD |
| CEO: | George Lasezkay |
| Employees: | 33 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
